CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Comfort, V. K.
Right arrow Articles by Yip, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Comfort, V. K.
Right arrow Articles by Yip, R. W.

Canadian Journal of Anesthesia, Vol 39, 349-352, Copyright © 1992 by Canadian Anesthesiologists' Society

ARTICLES

Naproxen premedication reduces postoperative tubal ligation pain

VK Comfort, WE Code, ME Rooney and RW Yip
Department of Anaesthesia, Royal University Hospital, Saskatoon, Saskatchewan.

This study evaluated the effectiveness of naproxen sodium oral premedication in reducing postoperative pain, analgesic requirements and day surgery length of stay in patients undergoing outpatient laparoscopic tubal ligations. We undertook a randomized, double-blind clinical trial on ASA I and ASA II patients undergoing outpatient laparoscopic tubal ligations. The treatment group received two capsules containing naproxen sodium, 275 mg each, and the control group received two identical capsules containing placebo. Postoperative visual analogue pain scores, analgesic requirements, side-effects and length of day surgery stay were studied. Forty-four patients completed the study with 21 patients in the naproxen group and 23 in the placebo group. There was a statistically significant difference between groups in terms of pain score (naproxen group 0.9 +/- 0.2 vs placebo group 3.5 +/- 0.6); patients requiring postoperative opioids (naproxen group 0% vs placebo group 34.8%); and time spent in the day surgery unit (naproxen group 168 +/- 13 min vs placebo group 188 +/- 15 min). There was no difference in the incidence of nausea and vomiting. Only one person developed a side-effect from the naproxen sodium which was minor gastric discomfort. This study shows that naproxen decreased the postoperative tubal ligation pain with less subsequent postoperative analgesic requirements, less time to street fitness and no increase in analgesic side-effects. We recommend the use of this premedication in outpatient laparoscopic tubal ligations.


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
A. S. Habib, H. A. Muir, W. D. White, T. E. Spahn, A. J. Olufolabi, T. W. Breen, and The Duke Women's Anesthesia Research Group
Intrathecal Morphine for Analgesia After Postpartum Bilateral Tubal Ligation
Anesth. Analg., January 1, 2005; 100(1): 239 - 243.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
J. M. Cooper, C. S. Carignan, D. Cher, and J. F. Kerin
Microinsert Nonincisional Hysteroscopic Sterilization
Obstet. Gynecol., July 1, 2003; 102(1): 59 - 67.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
D. C. Campbell, C. M. Riben, M. E. Rooney, L.-A. L. Crone, and R. W. Yip
Intrathecal Morphine for Postpartum Tubal Ligation Postoperative Analgesia
Anesth. Analg., October 1, 2001; 93(4): 1006 - 1011.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the Canadian Anesthesiologists' Society.